Diversity in enoyl-acyl carrier protein reductases

R. P. Massengo-Tiassé, J. E. Cronan

Research output: Contribution to journalReview articlepeer-review


The enoyl-acyl carrier protein reductase (ENR) is the last enzyme in the fatty acid elongation cycle. Unlike most enzymes in this essential pathway, ENR displays an unusual diversity among organisms. The growing interest in ENRs is mainly due to the fact that a variety of both synthetic and natural antibacterial compounds are shown to specifically target their activity. The primary anti-tuberculosis drug, isoniazid, and the broadly used antibacterial compound, triclosan, both target this enzyme. In this review, we discuss the diversity of ENRs, and their inhibitors in the light of current research progress.

Original languageEnglish (US)
Pages (from-to)1507-1517
Number of pages11
JournalCellular and Molecular Life Sciences
Issue number9
StatePublished - Jan 2009


  • Enoyl-acyl carrier protein reductase
  • Fatty acid biosynthesis
  • Fatty acid synthesis II
  • Medium-chain dehydrogenase reductase
  • Shortchain dehydrogenase reductase
  • Triclosan

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Pharmacology
  • Cellular and Molecular Neuroscience
  • Cell Biology


Dive into the research topics of 'Diversity in enoyl-acyl carrier protein reductases'. Together they form a unique fingerprint.

Cite this